Retrospective Analysis of Chest X-ray Severity Scoring System of COVID-19 Pneumonia
Launched by OSIJEK UNIVERSITY HOSPITAL · Jan 4, 2022
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how chest X-ray results can help understand the severity of pneumonia caused by COVID-19. Researchers will review the records of patients who were admitted to the COVID-19 Intensive Care Unit (ICU) at University Hospital Center Osijek during 2020 and 2021. They aim to see how changes in chest X-ray images relate to changes in blood tests and breathing function over time.
To be eligible for this study, participants need to have pneumonia caused by the SARS-CoV-2 virus and must have been admitted to the COVID-19 ICU. Unfortunately, patients with lung tumors or a history of lung surgery cannot take part in this trial. If you or a loved one qualifies, the study will involve reviewing past medical records, so there won’t be any new treatments or procedures required. This research could help improve how doctors monitor and treat patients with COVID-19 pneumonia in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Pneumonia caused by SARS-CoV-2 virus
- • Admission to the ICU COVID-19 unit
- Exclusion Criteria:
- • - Patients with lung tumors or history of lung resection
About Osijek University Hospital
Osijek University Hospital is a leading healthcare institution dedicated to advancing medical research and patient care. Located in Osijek, Croatia, the hospital integrates clinical practice with academic excellence, fostering a collaborative environment for healthcare professionals and researchers. With a commitment to innovation, Osijek University Hospital actively sponsors clinical trials aimed at evaluating new therapies and improving treatment outcomes across various medical fields. By leveraging state-of-the-art facilities and a multidisciplinary team, the hospital plays a pivotal role in contributing to the advancement of medical knowledge and enhancing the quality of life for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Osijek, , Croatia
Patients applied
Trial Officials
Nenad Nešković, PhD
Principal Investigator
University Hospital Osijek
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials